Long COVID: mechanisms, risk factors and recovery
- PMID: 36412084
- PMCID: PMC10103775
- DOI: 10.1113/EP090802
Long COVID: mechanisms, risk factors and recovery
Abstract
New findings: What is the topic of this review? The emerging condition of long COVID, its epidemiology, pathophysiological impacts on patients of different backgrounds, physiological mechanisms emerging as explanations of the condition, and treatment strategies being trialled. The review leads from a Physiological Society online conference on this topic. What advances does it highlight? Progress in understanding the pathophysiology and cellular mechanisms underlying Long COVID and potential therapeutic and management strategies.
Abstract: Long COVID, the prolonged illness and fatigue suffered by a small proportion of those infected with SARS-CoV-2, is placing an increasing burden on individuals and society. A Physiological Society virtual meeting in February 2022 brought clinicians and researchers together to discuss the current understanding of long COVID mechanisms, risk factors and recovery. This review highlights the themes arising from that meeting. It considers the nature of long COVID, exploring its links with other post-viral illnesses such as myalgic encephalomyelitis/chronic fatigue syndrome, and highlights how long COVID research can help us better support those suffering from all post-viral syndromes. Long COVID research started particularly swiftly in populations routinely monitoring their physical performance - namely the military and elite athletes. The review highlights how the high degree of diagnosis, intervention and monitoring of success in these active populations can suggest management strategies for the wider population. We then consider how a key component of performance monitoring in active populations, cardiopulmonary exercise training, has revealed long COVID-related changes in physiology - including alterations in peripheral muscle function, ventilatory inefficiency and autonomic dysfunction. The nature and impact of dysautonomia are further discussed in relation to postural orthostatic tachycardia syndrome, fatigue and treatment strategies that aim to combat sympathetic overactivation by stimulating the vagus nerve. We then interrogate the mechanisms that underlie long COVID symptoms, with a focus on impaired oxygen delivery due to micro-clotting and disruption of cellular energy metabolism, before considering treatment strategies that indirectly or directly tackle these mechanisms. These include remote inspiratory muscle training and integrated care pathways that combine rehabilitation and drug interventions with research into long COVID healthcare access across different populations. Overall, this review showcases how physiological research reveals the changes that occur in long COVID and how different therapeutic strategies are being developed and tested to combat this condition.
Keywords: ME/CFS; SARS-CoV-2; cardiovascular; coagulation; dysautonomia; fatigue; long COVID; respiratory.
© 2022 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
Conflict of interest statement
A.B. is a Trustee of the South Asian Health Foundation and of Long COVID SOS. B.R. has received speaker honorarium fees from Axcella Therapeutics.
Figures
Similar articles
-
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).Elife. 2023 Mar 22;12:e86002. doi: 10.7554/eLife.86002. Elife. 2023. PMID: 36947108 Free PMC article. Review.
-
Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses.Blood Rev. 2023 Jul;60:101075. doi: 10.1016/j.blre.2023.101075. Epub 2023 Mar 20. Blood Rev. 2023. PMID: 36963989 Free PMC article. Review.
-
Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.Medicina (Kaunas). 2021 Dec 24;58(1):28. doi: 10.3390/medicina58010028. Medicina (Kaunas). 2021. PMID: 35056336 Free PMC article.
-
Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.J Transl Med. 2023 Nov 1;21(1):775. doi: 10.1186/s12967-023-04588-4. J Transl Med. 2023. PMID: 37915075 Free PMC article.
-
Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.J Transl Med. 2022 Sep 24;20(1):429. doi: 10.1186/s12967-022-03638-7. J Transl Med. 2022. PMID: 36153556 Free PMC article.
Cited by
-
Inflammatory and Prothrombotic Biomarkers Contribute to the Persistence of Sequelae in Recovered COVID-19 Patients.Int J Mol Sci. 2023 Dec 14;24(24):17468. doi: 10.3390/ijms242417468. Int J Mol Sci. 2023. PMID: 38139298 Free PMC article.
-
Long COVID-19 Pathophysiology: What Do We Know So Far?Microorganisms. 2023 Sep 30;11(10):2458. doi: 10.3390/microorganisms11102458. Microorganisms. 2023. PMID: 37894116 Free PMC article. Review.
-
Developing a Blood Cell-Based Diagnostic Test for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Peripheral Blood Mononuclear Cells.Adv Sci (Weinh). 2023 Oct;10(30):e2302146. doi: 10.1002/advs.202302146. Epub 2023 Aug 31. Adv Sci (Weinh). 2023. PMID: 37653608 Free PMC article.
-
Laryngopharyngeal Reflux Patient Changes during the COVID-19 Quarantine.Medicina (Kaunas). 2023 Aug 17;59(8):1475. doi: 10.3390/medicina59081475. Medicina (Kaunas). 2023. PMID: 37629765 Free PMC article.
-
Coronavirus disease 2019 infection among working-aged people with multiple sclerosis and the impact of disease-modifying therapies.Mult Scler J Exp Transl Clin. 2024 Apr 27;10(2):20552173241248293. doi: 10.1177/20552173241248293. eCollection 2024 Apr-Jun. Mult Scler J Exp Transl Clin. 2024. PMID: 38680165 Free PMC article.
References
-
- Ajaz, S. , McPhail, M. J. , Singh, K. K. , Mujib, S. , Trovato, F. M. , Napoli, S. , & Agarwal, K. (2021). Mitochondrial metabolic manipulation by SARS‐CoV‐2 in peripheral blood mononuclear cells of patients with COVID‐19. American Journal of Physiology. Cell Physiology, 320(1), C57–C65. - PMC - PubMed
-
- Althaus, K. , Marini, I. , Zlamal, J. , Pelzl, L. , Singh, A. , Häberle, H. , Mehrländer, M. , Hammer, S. , Schulze, H. , Bitzer, M. , Malek, N. , Rath, D. , Bösmüller, H. , Nieswandt, B. , Gawaz, M. , Bakchoul, T. , & Rosenberger, P. (2021). Antibody‐induced procoagulant platelets in severe COVID‐19 infection. Blood, 137(8), 1061–1071. - PMC - PubMed
-
- Aranow, C. , Atish‐Fregoso, Y. , Lesser, M. , Mackay, M. , Anderson, E. , Chavan, S. , Zanos, T. P. , Datta‐Chaudhuri, T. , Bouton, C. , Tracey, K. J. , & Diamond, B. (2021). Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: A randomised, double‐blind, sham‐controlled pilot trial. Annals of the Rheumatic Diseases, 80(2), 203–208. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous